Dr Lalchandani Labs Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Mohit Lalchandani

Chief executive officer

₹1.4m

Total compensation

CEO salary percentage	n/a
CEO tenure	6yrs
CEO ownership	4.9%
Management average tenure	no data
Board average tenure	6.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mohit Lalchandani's remuneration changed compared to Dr Lalchandani Labs's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2024	n/a	n/a	₹9m
Jun 30 2024	n/a	n/a	₹7m
Mar 31 2024	₹1m	n/a	₹6m
Dec 31 2023	n/a	n/a	-₹304k
Sep 30 2023	n/a	n/a	-₹7m
Jun 30 2023	n/a	n/a	-₹11m
Mar 31 2023	₹1m	n/a	-₹16m
Dec 31 2022	n/a	n/a	-₹13m
Sep 30 2022	n/a	n/a	-₹11m
Jun 30 2022	n/a	n/a	-₹864k
Mar 31 2022	₹1m	₹1m	₹9m
Dec 31 2021	n/a	n/a	₹14m
Sep 30 2021	n/a	n/a	₹19m
Jun 30 2021	n/a	n/a	₹14m
Mar 31 2021	₹1m	₹1m	₹10m
Dec 31 2020	n/a	n/a	₹8m
Sep 30 2020	n/a	n/a	₹3m
Jun 30 2020	n/a	n/a	₹4m
Mar 31 2020	₹1m	₹1m	₹5m
Dec 31 2019	n/a	n/a	₹5m
Sep 30 2019	n/a	n/a	₹7m
Jun 30 2019	n/a	n/a	₹6m
Mar 31 2019	₹1m	₹1m	₹5m
Dec 31 2018	n/a	n/a	₹1m
Sep 30 2018	n/a	n/a	-₹3m
Jun 30 2018	n/a	n/a	-₹226k
Mar 31 2018	₹900k	₹900k	₹3m

Compensation vs Market: Mohit's total compensation ($USD17.05K) is below average for companies of similar size in the Indian market ($USD42.61K).

Compensation vs Earnings: Mohit's compensation has been consistent with company performance over the past year.

CEO

Mohit Lalchandani (38 yo)

6yrs

Tenure

₹1,440,000

Compensation

Mr. Mohit Lalchandani serves as Whole-Time Director of Dr Lalchandani Labs Ltd. and has been its Chief Executive Officer since November 2, 2018. Mr. Chandani holds Bachelor of Technology in the field of El...

Board Members

Name	Position	Tenure	Compensation	Ownership
Arjan Lalchandani	Chairman & MD	no data	₹1.44m	51.85% ₹ 40.4m
Mohit Lalchandani	CEO & Whole Time Director	6.2yrs	₹1.44m	4.87% ₹ 3.8m
Anchal Gupta	CFO & Executive Director	7.3yrs	₹600.00k	0.83% ₹ 650.7k
Prakash Jhuraney	Independent Director	6yrs	no data	no data
Rajiv Handa	Independent Director	no data	no data	no data
Swati Chandra	Non-Executive Director	2.7yrs	no data	no data

6.1yrs

Average Tenure

53.5yo

Average Age

Experienced Board: 541299's board of directors are considered experienced (6.1 years average tenure).

Dr Lalchandani Labs Management

Management criteria checks 3/4

Key information

Recent management updates

Chairman & MD recently bought ₹317k worth of stock

Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2024

Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer

Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Resignation of Monika Joshi as Company Secretary and Compliance Officer

Recent updates

Chairman & MD recently bought ₹317k worth of stock

First half 2025 earnings released: EPS: ₹0.35 (vs ₹0.20 loss in 1H 2024)

Investor sentiment improves as stock rises 20%

Dr Lalchandani Labs Limited to Report Q2, 2025 Results on Oct 14, 2024

Dr Lalchandani Labs Limited to Report First Half, 2025 Results on Oct 14, 2024

Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2024

Full year 2024 earnings released: EPS: ₹1.43 (vs ₹3.61 loss in FY 2023)

New minor risk - Financial data availability

Dr Lalchandani Labs Limited to Report Second Half, 2024 Results on May 30, 2024

Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer

Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Resignation of Monika Joshi as Company Secretary and Compliance Officer

Dr Lalchandani Labs Limited Announces Resignation of Monika Joshi as Company Secretary and Compliance Officer

First half 2024 earnings released: ₹0.20 loss per share (vs ₹2.24 loss in 1H 2023)

New major risk - Financial position

Less than half of directors are independent

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Resignation of Archana Jha from the Office of Company Secretary

Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2023

Dr Lalchandani Labs Limited Appoints Monika Joshi as Company Secretary and Compliance Officer, Effective August 27, 2023

Less than half of directors are independent

Less than half of directors are independent

New major risk - Revenue and earnings growth

Full year 2023 earnings released: ₹3.61 loss per share (vs ₹2.15 profit in FY 2022)

Less than half of directors are independent

Dr Lalchandani Labs Limited to Report Fiscal Year 2023 Results on May 30, 2023

Less than half of directors are independent

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Management Changes

Dr Lalchandani Labs Limited Appoints Archana Jha as Company Secretary & Compliance Officer

First half 2023 earnings released

Less than half of directors are independent

Dr Lalchandani Labs Limited to Report First Half, 2023 Results on Nov 14, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹2.15 (vs ₹2.33 in FY 2021)

Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2022

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Resignation of CS Swati Poddar as Company Secretary and Compliance Officer

Dr Lalchandani Labs Limited Resumes in Full Capacity At the Lab in Punjabi Bagh

Investor sentiment deteriorated over the past week

Dr Lalchandani Labs Limited to Report Fiscal Year 2022 Results on May 30, 2022

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2021 earnings released: EPS ₹2.33 (vs ₹1.09 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

New 90-day low: ₹13.00

Dr Lalchandani Labs Limited to Report First Half, 2021 Results on Nov 13, 2020

Market pulls back on stock over the past week

New 90-day high: ₹12.10

Full year earnings released - EPS ₹1.09

Dr Lalchandani Labs Limited to Report Fiscal Year 2020 Results on Jun 30, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age